Earlier this year, Cryoport opened its newest Global Logistics Center, based in Amsterdam. Cryoport’s “Chain of Compliance” processes are employed at the new facility, which was built so that it can be rapidly scaled to support additional demand for services. Cryoport clients, including Gilead Sciences, Novartis, Bellicum Pharmaceuticals, Immatics, Janssen Pharmaceuticals, and others, will benefit from Cryoport’s new Global Logistics Center. Additionally, Cryoport is the sole cryogenics logistics provider for the first two commercialized cell therapies, Novartis’ Kymriah and Kite’s Yescarta.